What’s New in Active Surveillance in 2021
Laurence Klotz, MD, FRCSC
Laurence Klotz, MD, FRCSC
Michael Hofman, MBBS, FRACP, FAANMS, FICIS, Director of the Prostate Cancer Theranostics and Imaging Center of Excellence (ProsTIC) at The Peter MacCallum Cancer Center in Melbourne, Australia.
Dr. Charles Ryan, M.D., Director of the Hematology, Oncology, Transplant Division in the Dept. of Medicine at the University of Minnesota
Daniel George, M.D., Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology in the Duke University School of Medicine
Jonathan I. Epstein M.D., Professor, Pathology, Oncology, and Urology at Johns Hopkins School of Medicine
Ashley Ross, MD, PhD, Associate Professor, Northwestern Feinberg School of Medicine
Saul Priceman, PhD, Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation at City of Hope
Dr. Michael Morris, Section Head of Prostate Cancer, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center in New York
William Brant, MD, FACS, FECSM, Urologist & Men’s Sexual Health Physician in Salt Lake City, Utah
Dr. Andrew Armstrong, Professor of Medicine, Surgery, Pharmacology and Cancer Biology and Director of Research, the Duke Cancer Institute Center for Prostate and Urologic Cancers at Duke University.
Dr. Judd Moul, Professor, Duke University Medical Center.
Dr. Michael Morris, Clinical Director, Memorial Sloan-Kettering Cancer Center in New York